Raymond James Trust’s Enzo Biochem, Inc. ENZ Stock Holding History

Raymond James Trust’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$19.1K	Hold	17,016	–	–	﹤0.01%	1312
2024 Q2	$18.5K	Hold	17,016	–	–	﹤0.01%	1254
2024 Q1	$21.6K	Hold	17,016	–	–	﹤0.01%	1249
2023 Q4	$23.7K	Hold	17,016	–	–	﹤0.01%	1207
2023 Q3	$23.8K	Hold	17,016	–	–	﹤0.01%	1149
2023 Q2	$31K	Hold	17,016	–	–	﹤0.01%	1179
2023 Q1	$41K	Hold	17,016	–	–	﹤0.01%	1148
2022 Q4	$24K	Hold	17,016	–	–	﹤0.01%	1131
2022 Q3	$38K	Hold	17,016	–	–	﹤0.01%	1065
2022 Q2	$35K	Hold	17,016	–	–	﹤0.01%	1078
2022 Q1	$49K	Hold	17,016	–	–	﹤0.01%	1152
2021 Q4	$55K	Hold	17,016	–	–	﹤0.01%	1176
2021 Q3	$60K	Hold	17,016	–	–	﹤0.01%	1118
2021 Q2	$54K	Hold	17,016	–	–	﹤0.01%	1121
2021 Q1	$59K	Hold	17,016	–	–	﹤0.01%	1085
2020 Q4	$43K	Hold	17,016	–	–	﹤0.01%	1035
2020 Q3	$36K	Hold	17,016	–	–	﹤0.01%	969
2020 Q2	$38K	Hold	17,016	–	–	﹤0.01%	923
2020 Q1	$43K	Sell	17,016 -6,097	-26%	-$15K	﹤0.01%	812
2019 Q4	$61K	Hold	23,113	–	–	﹤0.01%	949
2019 Q3	$83K	Hold	23,113	–	–	﹤0.01%	916
2019 Q2	$78K	Sell	23,113 -6,887	-23%	-$24.3K	﹤0.01%	892
2019 Q1	$82K	Hold	30,000	–	–	﹤0.01%	856
2018 Q4	$83K	Hold	30,000	–	–	0.01%	799
2018 Q3	$124K	Hold	30,000	–	–	0.01%	858
2018 Q2	$156K	Hold	30,000	–	–	0.01%	815
2018 Q1	$164K	Hold	30,000	–	–	0.01%	677
2017 Q4	$245K	Hold	30,000	–	–	0.02%	616
2017 Q3	$314K	Hold	30,000	–	–	0.02%	524
2017 Q2	$331K	Sell	30,000 -5,000	-14%	-$46.6K	0.02%	492
2017 Q1	$293K	Hold	35,000	–	–	0.02%	513
2016 Q4	$243K	Sell	35,000 -5,000	-13%	-$31.9K	0.02%	564
2016 Q3	$204K	Sell	40,000 -4,500	-10%	-$26.9K	0.02%	612
2016 Q2	$266K	Buy	+44,500	New	+$247K	0.02%	497

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Raymond James Trust's ENZ Position: Q3 2024 in Review

Raymond James Trust held its Enzo Biochem, Inc. (ENZ) position steady in Q3 2024 at 17,016 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.

Raymond James Trust first reported a position in ENZ in Q2 2016 and has held it in 34 quarters since. The position peaked at $331K in Q2 2017. 43 funds tracked by Wall St. Rank hold ENZ as of Q3 2024.

Raymond James Trust held 17,016 shares of Enzo Biochem, Inc. worth $19.1K as of Q3 2024.
Raymond James Trust left its Enzo Biochem, Inc. share count unchanged in Q3 2024.
Enzo Biochem, Inc. made up ﹤0.01% of Raymond James Trust's portfolio in Q3 2024, its #1312 holding.
Raymond James Trust first reported a position in Enzo Biochem, Inc. in Q2 2016 and has held it in 34 quarters since.
Raymond James Trust's Enzo Biochem, Inc. position peaked at $331K in Q2 2017.
43 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.